Last reviewed · How we verify
Lispro Insulin and glargine insulin
Lispro Insulin and glargine insulin is a Small molecule drug developed by Diabetes Care Center. It is currently in Phase 1 development.
At a glance
| Generic name | Lispro Insulin and glargine insulin |
|---|---|
| Sponsor | Diabetes Care Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes (NA)
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (PHASE2)
- Oral Anti Diabetic Agents in the Hospital (PHASE4)
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes (PHASE4)
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes (PHASE3)
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes (PHASE3)
- Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) (NA)
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lispro Insulin and glargine insulin CI brief — competitive landscape report
- Lispro Insulin and glargine insulin updates RSS · CI watch RSS
- Diabetes Care Center portfolio CI
Frequently asked questions about Lispro Insulin and glargine insulin
What is Lispro Insulin and glargine insulin?
Lispro Insulin and glargine insulin is a Small molecule drug developed by Diabetes Care Center.
Who makes Lispro Insulin and glargine insulin?
Lispro Insulin and glargine insulin is developed by Diabetes Care Center (see full Diabetes Care Center pipeline at /company/diabetes-care-center).
What development phase is Lispro Insulin and glargine insulin in?
Lispro Insulin and glargine insulin is in Phase 1.